U.S. markets open in 2 hours 21 minutes
  • S&P Futures

    4,281.00
    +4.25 (+0.10%)
     
  • Dow Futures

    33,996.00
    +33.00 (+0.10%)
     
  • Nasdaq Futures

    13,501.25
    +8.00 (+0.06%)
     
  • Russell 2000 Futures

    1,993.70
    +4.60 (+0.23%)
     
  • Crude Oil

    89.15
    +1.04 (+1.18%)
     
  • Gold

    1,783.60
    +6.90 (+0.39%)
     
  • Silver

    19.76
    +0.03 (+0.15%)
     
  • EUR/USD

    1.0177
    -0.0003 (-0.03%)
     
  • 10-Yr Bond

    2.8930
    0.0000 (0.00%)
     
  • Vix

    20.23
    +0.54 (+2.74%)
     
  • GBP/USD

    1.2057
    +0.0006 (+0.05%)
     
  • USD/JPY

    135.1490
    +0.0590 (+0.04%)
     
  • BTC-USD

    23,495.22
    -316.51 (-1.33%)
     
  • CMC Crypto 200

    558.66
    -14.16 (-2.47%)
     
  • FTSE 100

    7,512.91
    -2.84 (-0.04%)
     
  • Nikkei 225

    28,942.14
    -280.63 (-0.96%)
     

SOL Global's HeavenlyRx To Acquire Airganics

HeavenlyRx, a portfolio company of SOL Global Investments Corp (OTC: SOLCF), has announced it's entering into a letter of intent to acquire Airganics. The value of the deal is $10 million.

The acquisition of Airganics will allow HeavenlyRx, which holds controlling interests in hemp/CBD and THC-free cannabinoid wellness space, to add three new brands.

Airganics is focused on developing high-performance wellness products, which has three brands in its portfolio: MOXE, an aromatherapy diffuser that will include a CBD line later this year; Nutriair, an inhalable nutrient delivery service; and ENVY HEMP, which includes tinctures, capsules, vapes, and energy shots.

All brands are focused to capture the CBD wellness space and already have distribution channels.

Related Links:

Discussing Sol Global's M Hemp Biomass Investment With CEO Brady Cobb

OrganiGram Announces Proprietary Technology For Cannabis-Infused Edibles

See more from Benzinga

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.